TTL anticorps
-
- Antigène Voir toutes TTL Anticorps
- TTL (Tubulin tyrosine Ligase (TTL))
-
Reactivité
- Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp TTL est non-conjugé
-
Application
- Immunohistochemistry (IHC), Immunofluorescence (IF)
- Réactivité croisée
- Rat
- Purification
- Affinity purification
- Immunogène
- Recombinant protein corresponding to Mouse TTL
-
-
- Indications d'application
- IHC/IF (M,R) 1:2000-1:4000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS, pH 7.4, 0.02 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
-
- Antigène
- TTL (Tubulin tyrosine Ligase (TTL))
- Autre désignation
- TTL (TTL Produits)
- Synonymes
- anticorps 2410003M22Rik, anticorps 2700049H19Rik, anticorps AI848570, anticorps wu:fb93a09, anticorps zgc:153332, anticorps tubulin tyrosine ligase, anticorps Ttl, anticorps TTL, anticorps ttl
- Sujet
- Tubulin-tyrosine ligase (TTL) is the enzyme responsible for the reversible addition of a tyrosine residue at the carboxyl end of alpha-tubulin. TTL forms stable complexes with tubulin and inhibit tubulin polymerization. TTL is frequently suppressed during tumor progression with resulting accumulation of detyrosinated alpha-tubulin in tumor cells. TTL suppression in human cancers is associated with increased tumor aggressiveness.
- ID gène
- 69737
- NCBI Accession
- NP_081468
- UniProt
- P38585
- Pathways
- Regulation of Cell Size
-